Literature DB >> 26462512

[General aspects of structure, classification and replication of human papillomavirus].

Gerardo Santos-López1, Luis Márquez-Domínguez, Julio Reyes-Leyva, Verónica Vallejo-Ruiz.   

Abstract

Human papillomavirus (HPV) refers to a group of viruses which belongs to a larger group, commonly referred to as papillomaviruses. These viruses are taxonomically located in the Papillomaviridae family. Papillomaviruses are small, non-enveloped with a genome of double-stranded DNA and they have affinity for epithelial tissue. Many of them are associated with human infection; they induce benign lesions of the skin (warts) and mucous membranes (condylomas), but they are also associated with some epithelial malignancies, such as cervical cancer and other tumors of the urogenital tract. Papillomaviridae contains 16 genera, which are named with a Greek letter prefix and the termination papillomavirus, e.g., Alphapapillomavirus, Betapapillomavirus, etcetera. From the clinical point of view, human papillomaviruses infecting the genital tract (which are located in the genus Alphapapilomavirus) have been divided into two groups: those of low risk, associated with benign genital warts, and those of high risk, with oncogenic potential, which are the etiological agents of cervical cancer. In this paper we review some relevant aspects of the structure, replication cycle and classification of human papillomaviruses.

Entities:  

Keywords:  HPV classification; High risk HPV; Human papillomavirus

Mesh:

Substances:

Year:  2015        PMID: 26462512

Source DB:  PubMed          Journal:  Rev Med Inst Mex Seguro Soc        ISSN: 0443-5117


  9 in total

Review 1.  Anogenital warts in pediatric population.

Authors:  Miguel Costa-Silva; Inês Fernandes; Acácio Gonçalves Rodrigues; Carmen Lisboa
Journal:  An Bras Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.896

Review 2.  Cervical cancer in Ethiopia: a review of the literature.

Authors:  Awoke Derbie; Daniel Mekonnen; Endalkachew Nibret; Eyaya Misgan; Melanie Maier; Yimtubezinash Woldeamanuel; Tamrat Abebe
Journal:  Cancer Causes Control       Date:  2022-10-15       Impact factor: 2.532

Review 3.  Evolving role of immunotherapy in the treatment of refractory warts.

Authors:  Devinder M Thappa; Minu J Chiramel
Journal:  Indian Dermatol Online J       Date:  2016 Sep-Oct

4.  Human papillomavirus prevalence and genotype distribution among young women and men in Maputo city, Mozambique.

Authors:  Viegas Edna Omar; Augusto Orvalho; Ismael Nália; Malin Kaliff; Gabriella Lillsunde-Larsson; Torbjörn Ramqvist; Charlotta Nilsson; Kerstin Falk; Osman Nafissa; Jani Ilesh Vindorai; Sören Andersson
Journal:  BMJ Open       Date:  2017-07-17       Impact factor: 2.692

Review 5.  Low level of knowledge about cervical cancer among Ethiopian women: a systematic review and meta-analysis.

Authors:  Awoke Derbie; Daniel Mekonnen; Eyaya Misgan; Yihun Mulugeta Alemu; Yimtubezinash Woldeamanuel; Tamrat Abebe
Journal:  Infect Agent Cancer       Date:  2021-02-10       Impact factor: 2.965

6.  Dermoscopy Features of Cutaneous Warts.

Authors:  Mus'ab Al Rudaisat; Hao Cheng
Journal:  Int J Gen Med       Date:  2021-12-16

7.  Prevalence and Risk Factors of Human Papillomavirus in Male Patients: A Systematic Review and Meta-Analysis.

Authors:  María Inmaculada Rodríguez-Álvarez; Jose L Gómez-Urquiza; Husein Husein-El Ahmed; Luis Albendín-García; Juan Gómez-Salgado; Guillermo A Cañadas-De la Fuente
Journal:  Int J Environ Res Public Health       Date:  2018-10-10       Impact factor: 3.390

8.  Immunogenicity of next-generation HPV vaccines in non-human primates: Measles-vectored HPV vaccine versus Pichia pastoris recombinant protein vaccine.

Authors:  Gaurav Gupta; Viviana Giannino; Narayan Rishi; Reinhard Glueck
Journal:  Vaccine       Date:  2016-08-11       Impact factor: 3.641

Review 9.  HPV E6/E7 mRNA test for the detection of high grade cervical intraepithelial neoplasia (CIN2+): a systematic review.

Authors:  Awoke Derbie; Daniel Mekonnen; Yimtubezinash Woldeamanuel; Xaveer Van Ostade; Tamrat Abebe
Journal:  Infect Agent Cancer       Date:  2020-02-07       Impact factor: 2.965

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.